|
June 7, 2016
|
|
VIA EDGAR
John Grzeskiewicz
Division of Investment Management
U.S. Securities and Exchange Commission
100 F Street N.E.
Washington, DC 20549
|
|
RE:
|
BlackRock Health Sciences Trust
|
||
|
File Nos. 333-210770 & 811-21702
|
|
|
(a)
|
should the Securities and Exchange Commission (the “Commission”) or its staff, acting pursuant to delegated authority, declare the above-referenced Registration Statement effective, it does not foreclose the Commission from taking any action with respect to such Registration Statement;
|
|
|
(b)
|
the action of the Commission or its staff, acting pursuant to delegated authority in declaring the above-referenced Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure contained in such Registration Statement; and
|
|
|
(c)
|
the Registrant may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
|
|
Very truly yours,
|
||||
|
BLACKROCK HEALTH SCIENCES TRUST
|
||||
|
By:
|
/s/ Janey Ahn |
|
||
|
Name: Janey Ahn
|
||||
|
Title: Secretary
|
||||